Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $610.00

Intuitive Surgical (NASDAQ:ISRG) had its price objective increased by Stifel Nicolaus from $525.00 to $610.00 in a research note released on Thursday morning,Benzinga reports. They currently have a buy rating on the medical equipment provider’s stock.

Other equities research analysts have also recently issued research reports about the company. Raymond James upped their target price on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Mizuho upped their target price on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Piper Sandler reaffirmed an “overweight” rating and set a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Royal Bank of Canada upped their target price on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. Finally, BTIG Research upped their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $541.33.

Intuitive Surgical Trading Up 0.5 %

Shares of NASDAQ:ISRG opened at $550.41 on Thursday. The firm has a market cap of $196.05 billion, a PE ratio of 88.49, a price-to-earnings-growth ratio of 5.41 and a beta of 1.38. The company has a fifty day simple moving average of $516.21 and a 200 day simple moving average of $474.14. Intuitive Surgical has a 12-month low of $307.72 and a 12-month high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, equities research analysts forecast that Intuitive Surgical will post 5.45 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 188 shares of the company’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $101,332.00. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,720,023. This represents a 2.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, General Counsel Gary Loeb sold 300 shares of the company’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the sale, the general counsel now owns 1,595 shares in the company, valued at $757,625. This trade represents a 15.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 51,023 shares of company stock worth $26,384,247. 0.90% of the stock is owned by corporate insiders.

Institutional Trading of Intuitive Surgical

A number of large investors have recently bought and sold shares of ISRG. Ridgewood Investments LLC bought a new stake in Intuitive Surgical in the second quarter valued at $26,000. Godsey & Gibb Inc. grew its holdings in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the last quarter. LGT Financial Advisors LLC grew its holdings in shares of Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 54 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical during the third quarter worth $33,000. Finally, Mark Sheptoff Financial Planning LLC bought a new stake in shares of Intuitive Surgical during the second quarter worth $37,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.